StockData
Eikon Therapeutics, Inc. logo

Eikon Therapeutics, Inc. (EIKN) shareholders

EIKNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$5.15−0.23 (-4.36%)

Close on Nov 17, 2026Market cap $278.95MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
48.9%
27M of 54M shares
Institutional holders
77
37 new, 12 sold out
Net institutional buying
3M
In Q2 2026
Insider trades, 12 months
10 buys · 0 sales
Net bought $52.15M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Tim Kutzkey
Joint filing with Peter Svennilson (11.60%), The Column Group IV GP, LP (8.30%) and 1 more
6,353,71211.60%13D (active)Feb 6, 2026
FMR LLC
Joint filing with Abigail P. Johnson (10.20%)
5,520,15210.20%13G (passive) amendmentSep 30, 2026
Abigail P. Johnson
Joint filing with FMR LLC (9.20%)
4,993,9069.20%13G (passive) amendmentJun 30, 2026
James B. Tananbaum4,148,5197.70%13G (passive)Feb 4, 2026
BlackRock Portfolio Management LLC3,002,7375.50%13G (passive)Mar 31, 2026
Perlmutter Roger M2,893,1715.20%13G (passive)Feb 4, 2026
Abu Dhabi Investment Authority2,816,7145.20%13G (passive)Feb 4, 2026
Innovation Endeavors III GP, LLC
Joint filing with Innovation Endeavors III LP (5.00%)
2,723,2265.00%13G (passive)Mar 31, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of EIKNValueChange% of portfolio
FMR LLC4,993,9069.22%$65.17M+1,157,0760.00%
BlackRock, Inc.4,281,4257.90%$55.87M+962,0460.00%
Foresite Capital Management IV, LLC1,943,6823.59%$25.37M–8.74%
Merck & Co., Inc.1,666,6663.08%$21.75M–4.13%
T. Rowe Price Investment Management, Inc.1,595,2742.95%$20.82M+372,7870.01%
Foresite Capital Management V, LLC1,318,9832.44%$17.21M–4.75%
Capital World Investors1,175,9442.17%$15.35M+32,3070.00%
Price T Rowe Associates Inc /Md/1,005,0351.86%$13.12M+29,2010.00%
Vanguard Capital Management LLC922,7071.70%$12.04M−46,7240.00%
EcoR1 Capital, LLC732,6061.35%$9.56M–0.46%
Alliancebernstein L.P.641,8881.19%$6.79M−380,3000.00%
Geode Capital Management, LLC556,9551.03%$7.27M+283,0240.00%
Baker Bros. Advisors LP555,5551.03%$7.25M–0.04%
Soros Capital Management LLC484,6720.89%$6.32M–1.13%
StepStone Group LP395,3400.73%$5.16M–0.24%
Canada Pension Plan Investment Board379,0240.70%$4.95M–0.00%
State Street Corp354,0930.65%$4.62M+313,9430.00%
Franklin Resources Inc350,0000.65%$4.57M–0.00%
General Catalyst Group Management, LLC305,2330.56%$3.98M–2.11%
UBS Group AG263,9320.49%$3.44M+164,5240.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 20267727M48.9%37 / 179 / 125M2M
Q1 20265224M43.8%52 / 00 / 024M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

FundShares% of EIKNValue% of fundAs of
Fidelity Contrafund1,275,8002.36%$16.65M0.01%Jun 30, 2026
SMALLCAP World Fund Inc1,143,6372.11%$14.92M0.02%Jun 30, 2026
Select Biotechnology Portfolio974,3331.80%$10.56M0.20%May 31, 2026
T. Rowe Price Small-Cap Value Fund, Inc.926,0461.71%$12.08M0.11%Jun 30, 2026
BlackRock Health Sciences Opportunities Portfolio722,3891.33%$7.83M0.13%May 29, 2026
Vanguard Total Stock Market Index Fund660,1171.22%$8.61M0.00%Jun 30, 2026
Fidelity Growth Company Fund602,3001.11%$6.53M0.01%May 31, 2026
iShares Russell 2000 ETF510,6610.94%$6.66M0.01%Jun 30, 2026
T. Rowe Price Health Sciences Fund, Inc.349,0980.64%$4.56M0.04%Jun 30, 2026
T. Rowe Price New Horizons Fund, Inc.331,0110.61%$4.32M0.03%Jun 30, 2026
Fidelity Contrafund K6265,4690.49%$3.46M0.01%Jun 30, 2026
Fidelity Small Cap Index Fund237,7560.44%$2.19M0.01%Jul 31, 2026
Vanguard Extended Market Index Fund235,1740.43%$3.07M0.00%Jun 30, 2026
Fidelity Growth Company K6 Fund169,2280.31%$1.83M0.01%May 31, 2026
Fidelity Series Growth Company Fund154,4000.29%$1.67M0.01%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Roger M. PerlmutterSee remarks, Director1,475,8562.72%Mar 4, 2026
Roy D. BaynesChief Medical Officer––Mar 4, 2026
Michael A. KlobucharChief Operating Officer––Mar 4, 2026
Benjamin Bruno ThornerSee Remarks––Mar 4, 2026
Alfred Lloyd Bowie Jr.Chief Financial Officer51,5720.10%Mar 4, 2026
Ma. Fatima FranciscoDirector––Jun 15, 2026
Kenneth C. FrazierDirector111,1110.21%Mar 4, 2026
Robert Luther HuffinesDirector––Mar 4, 2026
Josh WolfeDirector, 10% owner2,387,7054.41%Feb 6, 2026
David W. MelineDirector––Feb 4, 2026
Leon ChenDirector––Feb 4, 2026
Tim Kutzkey10% owner5,869,34310.84%Sep 8, 2026
TCG Opportunity III GP, LLC10% owner––Sep 8, 2026
Column Group Opportunity III GP, LP10% owner––Sep 8, 2026
Column Group IV-A, LP10% owner––Sep 8, 2026
Column Group IV, LP10% owner––Sep 8, 2026
Column Group Opportunity III, LP10% owner3,658,5986.75%Sep 8, 2026
Peter Svennilson10% owner––Sep 8, 2026
Column Group IV GP, LP10% owner––Sep 8, 2026
Foresite Capital Opportunity Management V, LLC10% owner1,676,3993.09%Feb 6, 2026
Foresite Capital Opportunity Fund V, L.P.10% owner––Feb 6, 2026
Peter Hebert10% owner––Feb 6, 2026
Foresite Capital Fund IV, L.P.10% owner––Feb 6, 2026
Foresite Capital Management IV, LLC10% owner––Feb 6, 2026
Foresite Capital VI-A, LLC10% owner––Feb 6, 2026
Lux Ventures V, L.P.10% owner2,387,7054.41%Feb 6, 2026
Lux Total Opportunities, L.P.10% owner––Feb 6, 2026
Lux Venture Partners V, LLC10% owner––Feb 6, 2026
Lux Co-Invest Opportunities II, L.P.10% owner––Feb 6, 2026
Foresite Capital VI-A Management, LLC10% owner––Feb 6, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Tim Kutzkey
10% owner
Sep 3, 2026Buy+89,200$11.56$1.03M89,200
Roger M. Perlmutter
See remarks, Director
Feb 6, 2026Conversion+284,857––284,857
Column Group Opportunity III, LP
10% owner
Feb 6, 2026Conversion+47,898––95,499
Column Group Opportunity III, LP
10% owner
Feb 6, 2026Conversion+44,249––47,601
Column Group Opportunity III, LP
10% owner
Feb 6, 2026Conversion+110,928––2,874,816
Column Group Opportunity III, LP
10% owner
Feb 6, 2026Conversion+1,403,568––2,763,888
Column Group Opportunity III, LP
10% owner
Feb 6, 2026Conversion+1,296,629––1,360,320
Column Group Opportunity III, LP
10% owner
Feb 6, 2026Buy+1,437,323$18.00$25.87M4,312,139
Column Group Opportunity III, LP
10% owner
Feb 6, 2026Buy+49,556$18.00$892.01K148,840
Column Group Opportunity III, LP
10% owner
Feb 6, 2026Conversion+3,785––99,284
Column Group Opportunity III, LP
10% owner
Feb 6, 2026Conversion+688,283––688,283
Column Group Opportunity III, LP
10% owner
Feb 6, 2026Buy+630,881$18.00$11.36M1,319,164
Josh Wolfe
Director, 10% owner
Feb 6, 2026Conversion+2,387,705––2,387,705
Josh Wolfe
Director, 10% owner
Feb 6, 2026Conversion+1,151,540––1,290,428
Josh Wolfe
Director, 10% owner
Feb 6, 2026Conversion+2,155,765––2,294,653
Lux Ventures V, L.P.
10% owner
Feb 6, 2026Conversion+2,387,705––2,387,705
Lux Ventures V, L.P.
10% owner
Feb 6, 2026Conversion+1,151,540––1,290,428
Lux Ventures V, L.P.
10% owner
Feb 6, 2026Conversion+2,155,765––2,294,653
Kenneth C. Frazier
Director
Feb 4, 2026Buy+111,111$18.00$2.00M111,111
Foresite Capital Opportunity Management V, LLC
10% owner
Feb 4, 2026Conversion+335,521––1,676,399
Foresite Capital Opportunity Management V, LLC
10% owner
Feb 4, 2026Conversion+408,725––408,725
Foresite Capital Opportunity Management V, LLC
10% owner
Feb 4, 2026Conversion+38,133––425,852
Foresite Capital Opportunity Management V, LLC
10% owner
Feb 4, 2026Conversion+922––387,719
Foresite Capital Opportunity Management V, LLC
10% owner
Feb 4, 2026Conversion+37,855––386,797
Foresite Capital Opportunity Management V, LLC
10% owner
Feb 4, 2026Conversion+348,942––348,942
Foresite Capital Opportunity Management V, LLC
10% owner
Feb 4, 2026Conversion+458,855––1,263,428
Foresite Capital Opportunity Management V, LLC
10% owner
Feb 4, 2026Conversion+67,207––804,573
Foresite Capital Opportunity Management V, LLC
10% owner
Feb 4, 2026Conversion+1,626––737,366
Foresite Capital Opportunity Management V, LLC
10% owner
Feb 4, 2026Conversion+37,855––735,740
Foresite Capital Opportunity Management V, LLC
10% owner
Feb 4, 2026Conversion+697,885––697,885
Foresite Capital Opportunity Management V, LLC
10% owner
Feb 4, 2026Conversion+229,428––1,943,682
Foresite Capital Opportunity Management V, LLC
10% owner
Feb 4, 2026Conversion+37,855––1,714,254
Foresite Capital Opportunity Management V, LLC
10% owner
Feb 4, 2026Buy+55,555$18.00$999.99K1,318,983
Foresite Capital Opportunity Management V, LLC
10% owner
Feb 4, 2026Conversion+1,340,878––1,340,878
Josh Wolfe
Director, 10% owner
Feb 4, 2026Buy+138,888$18.00$2.50M138,888
Josh Wolfe
Director, 10% owner
Feb 4, 2026Buy+138,888$18.00$2.50M138,888
Lux Ventures V, L.P.
10% owner
Feb 4, 2026Buy+138,888$18.00$2.50M138,888
Lux Ventures V, L.P.
10% owner
Feb 4, 2026Buy+138,888$18.00$2.50M138,888

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
14.49%
6M shares short
Days to cover
10.5
At 1M shares a day
Change since last report
-13.1%
From 6M shares
Short volume, 20 days
55.7%
Of volume reported to FINRA

Shares sold short, last 9 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Eikon Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 60,968 shares on Sep 25, 2026 over the last 90 days.

See a number that looks wrong?